跳至主要内容
临床试验/CTRI/2013/09/003981
CTRI/2013/09/003981招募中未知

Preoperative chemoradiation and surgery versus surgery alone in gastroesophageal junction adenocarcinoma of oesophagus â??A Randomized controlled trial

not applicable0 个研究点目标入组 160 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Age < 70 years
  • 2.Adenocarcinoma
  • 3.Good performance status (Eastern Cooperative Oncology Group [ECOG] grades 0, 1 and 2) i.e the patient should not be spending more than 50% of his time in Bed.
  • 4.Swallowing capacity at preop or preop neoadjuvant is a minimum of oral intake (liquid or semisolid)
  • 5.Contrast enhanced computerized tomographic (CECT) scan suggesting a potentially resectable lesion. The features of resectability assessed on CECT scan will include - no evidence of infiltration of mediastinal structures such as the aorta (angle of contact <900), no obliteration of the triangular fat space between the esophagus, aorta, and spine, and pericardium, and no evidence of tracheobronchial fistula or tumor extension into the airway lumen.
  • 6.No evidence of distant metastasis on CECT of neck , thorax and abdomen.

排除标准

  • 1.Patient refuses consent for the study
  • 2.Co-morbid conditions which would preclude oesophagectomy
  • a.Poor performance status (ECOG > 2)
  • b.American Society of Anesthesiologists class IV
  • 3.Metastatic disease detected on evaluation
  • 4.Involvement of mediastinal structures as described in the inclusion criteria
  • 5.Carcinoma involving upper third of the esophagus.
  • 6.Previous radiotherapy or chemotherapy

研究者

相似试验

尚未招募
3 期
Surgery first vs chemotherapy first in early triple negative and HER2 positive breast cancer.
CTRI/2024/02/063118Tata Memorial Centre
进行中(未招募)
1 期
clinical study to evaluate the efficacy of a two drug combination versus a single drug therapy in the treatment of locally advanced rectal cancer.locally advanced rectal cancerMedDRA version: 17.0Level: PTClassification code 10038050Term: Rectal cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.0Level: PTClassification code 10038049Term: Rectal cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)
EUCTR2006-006532-21-DEEORTC1,094
进行中(未招募)
不适用
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancerRectal cancerLocally Advanced Rectal CancerCancer - Bowel - Back passage (rectum) or large bowel (colon)
ACTRN12608000403336Australasian Gastro-Intestinal Trials Group (AGITG)1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1Level: LLTClassification code 10038050Term: Rectal cancer stage IIIMedDRA version: 9.1Level: LLTClassification code 10038049Term: Rectal cancer stage II
EUCTR2006-006532-21-FREORTC1,090
进行中(未招募)
1 期
Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin vs. capecitabine alone in locally advanced rectal cancer (PETACC-6) - PETACC-6locally advanced rectal cancerMedDRA version: 9.1 Level: LLT Classification code 10038050 Term: Rectal cancer stage IIIMedDRA version: 9.1 Level: LLT Classification code 10038049 Term: Rectal cancer stage II
EUCTR2006-006532-21-GBEuropean Organization for Research and Treatment of Cancer1,094